Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease

• Chihiro Udagawa,

  Roles Formal analysis, Writing – original draft

  Affiliation Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan

  http://orcid.org/0000-0002-3430-2555

  ⨯
• Hidehito Horinouchi,

  Roles Data curation, Resources

  Affiliation Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Kouya Shiraishi,

  Roles Data curation, Formal analysis

  Affiliation Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Takashi Kohno,

  Roles Data curation, Formal analysis

  Affiliation Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan

  ⨯
• Takuji Okusaka,

  Roles Data curation, Resources

  Affiliation Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Hideki Ueno,

  Roles Data curation, Resources

  Affiliation Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Kenji Tamura,

  Roles Data curation, Resources

  Affiliation Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Yuichiro Ohe,

  Roles Data curation, Resources

  Affiliation Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Hitoshi Zembutsu

  Roles Conceptualization, Formal analysis, Writing – original draft

  * E-mail: hitoshi.zembutsu@jfcr.or.jp

  Affiliations Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan, Project for Development of Liquid Biopsy Diagnosis, Japanese Foundation for Cancer Research, Research Institute, Tokyo, Japan

  http://orcid.org/0000-0002-1674-1968

  ⨯